{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:16:07Z","timestamp":1774793767267,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T00:00:00Z","timestamp":1222387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T00:00:00Z","timestamp":1222387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/cgt.2008.67","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T10:24:20Z","timestamp":1222424660000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"K","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Abei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K K","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,26]]},"reference":[{"key":"BFcgt200867_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID . Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167\u2013176.","journal-title":"Lancet Oncol"},{"key":"BFcgt200867_CR2","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2618::AID-CNCR29>3.0.CO;2-H","volume":"83","author":"JH Donohue","year":"1998","unstructured":"Donohue JH, Stewart AK, Menck HR . The national cancer data base report on carcinoma of the gallbladder, 1989\u20131995. Cancer 1998; 83: 2618\u20132628.","journal-title":"Cancer"},{"key":"BFcgt200867_CR3","first-page":"5258","volume":"54","author":"T Osaki","year":"1994","unstructured":"Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I et al. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 1994; 54: 5258\u20135261.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR4","first-page":"1341","volume":"56","author":"T Tanaka","year":"1996","unstructured":"Tanaka T, Kanai F, Okabe S, Yoshida Y, Wakimoto H, Hamada H et al. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res 1996; 56: 1341\u20131345.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1006\/bbrc.1997.6124","volume":"231","author":"T Tanaka","year":"1997","unstructured":"Tanaka T, Kanai F, Lan K-H, Ohashi M, Shiratori Y, Yoshida Y et al. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. Biochem Biophys Res Commun 1997; 231: 775\u2013779.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt200867_CR6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/sj.gt.3300728","volume":"5","author":"K Brand","year":"1998","unstructured":"Brand K, Loser P, Arnold W, Bartels T, Strauss M . Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk\/GCV approach. Gene Ther 1998; 5: 1363\u20131371.","journal-title":"Gene Ther"},{"key":"BFcgt200867_CR7","first-page":"5283","volume":"55","author":"S Kaneko","year":"1995","unstructured":"Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995; 55: 5283\u20135287.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/scbi.1998.0119","volume":"9","author":"S Hammarstrom","year":"1999","unstructured":"Hammarstrom S . The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999; 9: 67\u201381.","journal-title":"Semin Cancer Biol"},{"key":"BFcgt200867_CR9","first-page":"4906","volume":"59","author":"T Kijima","year":"1999","unstructured":"Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H et al. Application of the Cre recombinase\/lox P system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer. Cancer Res 1999; 59: 4906\u20134911.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR10","first-page":"2337","volume":"62","author":"MK Nyati","year":"2002","unstructured":"Nyati MK, Sreekumar A, Li S, Zhang M, Rynkiewicz SD, Chinnaiyan AM et al. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res 2002; 62: 2337\u20132342.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1006\/mthe.2001.0273","volume":"3","author":"PE Koch","year":"2001","unstructured":"Koch PE, Guo ZS, Kagawa S, Gu J, Roth JA, Fang B . Augmented transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene-regulatory system. Mol Ther 2001; 3: 278\u2013283.","journal-title":"Mol Ther"},{"key":"BFcgt200867_CR12","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","volume":"2","author":"EA Chiocca","year":"2002","unstructured":"Chiocca EA . Oncolytic viruses. Nat Rev 2002; 2: 938\u2013950.","journal-title":"Nat Rev"},{"key":"BFcgt200867_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cgt.7700771","volume":"12","author":"B Everts","year":"2005","unstructured":"Everts B, van der Poel HG . Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther 2005; 12: 141\u2013161.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt200867_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.bjc.6600006","volume":"86","author":"S Ries","year":"2002","unstructured":"Ries S, Korn WM . ONYX-015: mechanism of action and clinical potential of a replication-selective adenovirus. Br J Cancer 2002; 86: 5\u201311.","journal-title":"Br J Cancer"},{"key":"BFcgt200867_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"FR Khuri","year":"2000","unstructured":"Khuri FR, Nemunaitis J, Ganly I, Arseneau J, Tannock IF, Romel L et al. A controlled trial of intratumoral ONYX-015, a selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000; 6: 879\u2013885.","journal-title":"Nat Med"},{"key":"BFcgt200867_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/80474","volume":"6","author":"C Heise","year":"2000","unstructured":"Heise C, Hermiston T, Johnson L, Brooks G, Jhoannes AS, Williams A et al. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med 2000; 6: 1134\u20131139.","journal-title":"Nat Med"},{"key":"BFcgt200867_CR17","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1128\/JVI.74.13.6147-6155.2000","volume":"74","author":"S Doronin","year":"2000","unstructured":"Doronin S, Toth K, Kuppuswamy M, Ward P, Tollefson AE, Wold WSM . Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein. J Virol 2000; 74: 6147\u20136155.","journal-title":"J Virol"},{"key":"BFcgt200867_CR18","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.1128\/JVI.72.12.9470-9478.1998","volume":"72","author":"T Rothmann","year":"1998","unstructured":"Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, Hausen H . Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J Virol 1998; 72: 9470\u20139478.","journal-title":"J Virol"},{"key":"BFcgt200867_CR19","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1128\/JVI.73.7.5333-5344.1999","volume":"73","author":"JN Harada","year":"1999","unstructured":"Harada JN, Berk AJ . p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J Virol 1999; 73: 5333\u20135344.","journal-title":"J Virol"},{"key":"BFcgt200867_CR20","first-page":"693","volume":"9","author":"D Makower","year":"2003","unstructured":"Makower D, Rozenblit A, Kaufman H, Edelman M, Lane ME, Zwiebel J et al. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin Cancer Res 2003; 9: 693\u2013702.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200867_CR21","first-page":"33","volume":"9","author":"S Wadler","year":"2003","unstructured":"Wadler S, Yu B, Tan J-Y, Kaleya R, Rozenblit A, Makower D et al. Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gallbladder carcinoma implants. Clin Cancer Res 2003; 9: 33\u201343.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200867_CR22","first-page":"4434","volume":"63","author":"K Fukuda","year":"2003","unstructured":"Fukuda K, Abei M, Ugai H, Seo E, Wakayama M, Murata T et al. E1A, E1B double-restricted oncolytic adenovirusfor gene therapy of gallbladder cancer. Cancer Res 2003; 63: 4434\u20134440.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR23","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/sj.onc.1207321","volume":"23","author":"C Gomez-Manzano","year":"2004","unstructured":"Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H et al. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene 2004; 23: 1821\u20131828.","journal-title":"Oncogene"},{"key":"BFcgt200867_CR24","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1158\/1078-0432.CCR-0349-03","volume":"10","author":"RL Chu","year":"2004","unstructured":"Chu RL, Post DE, Khuri FR, Van Meir EG . Use of replicating oncolytic adenoviruses in combination therapy for cancer. Clin Cancer Res 2004; 10: 5299\u20135312.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200867_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/hum.1998.9.9-1323","volume":"9","author":"SO Freytag","year":"1998","unstructured":"Freytag SO, Rogulski KR, Paielli DL, Gilbert JD, Kim JH . A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double-suicide gene, and radiotherapy. Human Gene Ther 1998; 9: 1323\u20131333.","journal-title":"Human Gene Ther"},{"key":"BFcgt200867_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/10430340050016166","volume":"11","author":"KR Rogulski","year":"2000","unstructured":"Rogulski KR, Wing MS, Paielli DL, Gilbert JD, Kim JH, Freytag SO . Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Human Gene Ther 2000; 11: 67\u201376.","journal-title":"Human Gene Ther"},{"key":"BFcgt200867_CR27","first-page":"410","volume":"59","author":"O Wildner","year":"1999","unstructured":"Wildner O, Blaese RM, Morris JC . Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res 1999; 59: 410\u2013413.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.gt.3300810","volume":"6","author":"O Wildner","year":"1999","unstructured":"Wildner O, Morris JC, Vahanian NN, Ford Jr H, Ramsey WJ, Blaese RM . Adenoviral vectors capable of replication improve the efficacy of HSVtk\/GCV suicide gene therapy of cancer. Gene Ther 1999; 6: 57\u201362.","journal-title":"Gene Ther"},{"key":"BFcgt200867_CR29","first-page":"8743","volume":"61","author":"D Nanda","year":"2001","unstructured":"Nanda D, Vogels R, Havenga H, Azezaat CJ, Bout A, Smit PS . Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Cancer Res 2001; 61: 8743\u20138750.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/mthe.1999.0014","volume":"1","author":"JC Morris","year":"2000","unstructured":"Morris JC, Wildner O . Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk. Mol Ther 2000; 1: 56\u201362.","journal-title":"Mol Ther"},{"key":"BFcgt200867_CR31","first-page":"4167","volume":"60","author":"O Wildner","year":"2000","unstructured":"Wildner O, Morris JC . The role of the E1B 55\u2009kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Cancer Res 2000; 60: 4167\u20134174.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.gt.3301489","volume":"8","author":"ES Lambright","year":"2001","unstructured":"Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, et al. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther 2001; 8: 946\u2013953.","journal-title":"Gene Ther"},{"key":"BFcgt200867_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/0008-5472.CAN-04-2374","volume":"65","author":"E Seo","year":"2005","unstructured":"Seo E, Abei M, Wakayama M, Fukuda K, Ugai H, Murata T et al. Effective gene therapy for biliary tract cancer by a conditionally replicative adenovirus carrying uracil phosphoribosyltransferase (UPRT) gene: Significance of timing of 5-fluorouracil administration. Cancer Res 2005; 65: 546\u2013552.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/path.1711700111","volume":"170","author":"D Kamel","year":"1993","unstructured":"Kamel D, Paakko P, Nuorva K, Vahakangas K, Soini Y . p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J Pathol 1993; 170: 67\u201372.","journal-title":"J Pathol"},{"key":"BFcgt200867_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M","volume":"77","author":"K Hanada","year":"1996","unstructured":"Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G . K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 1996; 77: 452\u2013458.","journal-title":"Cancer"},{"key":"BFcgt200867_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ijc.1639","volume":"97","author":"K Caca","year":"2002","unstructured":"Caca K, Feisthammel J, Klee K, Tannapeel A, Witzigmann H, Wittekind C et al. Inactivation of the INK4A\/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Int J Cancer 2002; 97: 481\u2013488.","journal-title":"Int J Cancer"},{"key":"BFcgt200867_CR37","first-page":"2756","volume":"55","author":"S Yoshida","year":"1995","unstructured":"Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M et al. Mutations of p16Ink4\/CDKN2 and p15Ink4B\/MTS2 gene in biliary tract cancers. Cancer Res 1995; 55: 2756\u20132760.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR38","first-page":"4096","volume":"6","author":"YZ Shi","year":"2000","unstructured":"Shi YZ, Hui AM, Li X, Takayama T, Makuuchi M . Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas. Clin Cancer Res 2000; 6: 4096\u20134100.","journal-title":"Clin Cancer Res"},{"key":"BFcgt200867_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/path.1711700112","volume":"170","author":"P Maxwell","year":"1993","unstructured":"Maxwell P, Davis RI, Sloan J . Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. J Pathol 1993; 170: 73\u201376.","journal-title":"J Pathol"},{"key":"BFcgt200867_CR40","first-page":"3411","volume":"59","author":"N Shinoura","year":"1999","unstructured":"Shinoura N, Yoshida Y, Tsunoda R, Ohashi M, Zhang W, Asai A et al. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas. Cancer Res 1999; 59: 3411\u20133416.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/j.1460-2075.1990.tb08088.x","volume":"9","author":"S Katho","year":"1990","unstructured":"Katho S, Ozawa K, Kondoh S, Soeda E, Israel A, Shiroki K et al. Identification of sequences responsible for positive and negative regulation by E1A in the promoter of H-2Kbml class I MHC gene. EMBO J 1990; 9: 127\u2013135.","journal-title":"EMBO J"},{"key":"BFcgt200867_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.cgt.7700001","volume":"6","author":"R Alemany","year":"1999","unstructured":"Alemany R, Lai S, Lou Y-C, Jan H-Y, Fang X, Zhang W-W . Complementary adenoviral vectors for oncolysis. Cancer Gene Ther 1999; 6: 21\u201325.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt200867_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/10430340050015978","volume":"11","author":"F Motoi","year":"2000","unstructured":"Motoi F, Sunamura M, Ding L, Duda DG, Yoshida Y, Zhang W et al. Effective gene therapy for pancreatic cancer by cytokines mediated by restricted replication-competent adenovirus. Hum Gene Ther 2000; 11: 223\u2013235.","journal-title":"Hum Gene Ther"},{"key":"BFcgt200867_CR44","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/sj.gt.3302001","volume":"10","author":"Y Nagayama","year":"2003","unstructured":"Nagayama Y, Nakao K, Hayakawa T, Niwa M . Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model. Gene Ther 2003; 10: 1400\u20131403.","journal-title":"Gene Ther"},{"key":"BFcgt200867_CR45","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-04-1200","volume":"64","author":"C-T Lee","year":"2004","unstructured":"Lee C-T, Park K-H, Yanagisawa K, Adachi Y, Ohm JF, Nadaf S et al. Combination therapy with conditionally replicative adenovirus and replication defective adenovirus. Cancer Res 2004; 64: 6660\u20136665.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/368520a0","volume":"368","author":"F Liu","year":"1994","unstructured":"Liu F, Green MR . Promoter targeting by adenovirus E1A through interaction with different cellular DNA-binding domains. Nature 1994; 368: 520\u2013525.","journal-title":"Nature"},{"key":"BFcgt200867_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.genet.31.1.177","volume":"31","author":"J Flint","year":"1997","unstructured":"Flint J, Shenk T . Viral transactivating proteins. Annu Rev Genet 1997; 31: 177\u2013212.","journal-title":"Annu Rev Genet"},{"key":"BFcgt200867_CR48","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1074\/jbc.270.8.3602","volume":"8","author":"W Hauck","year":"1995","unstructured":"Hauck W, Stanners CP . Transcriptional regulation of the carcinoembryonic antigen gene. J Biol Chem 1995; 8: 3602\u20133610.","journal-title":"J Biol Chem"},{"key":"BFcgt200867_CR49","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","volume":"66","author":"MA Thomas","year":"2006","unstructured":"Thomas MA, Spencer JF, La Regina MC, Dhar D, Tollefson AE, Toth K et al. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res 2006; 66: 1270\u20131276.","journal-title":"Cancer Res"},{"key":"BFcgt200867_CR50","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F . The Rb and p53 pathways in cancer. Cancer Cell 2002; 2: 103\u2013112.","journal-title":"Cancer Cell"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt200867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt200867","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt200867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:29:49Z","timestamp":1647948589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt200867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,26]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFcgt200867"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2008.67","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,26]]},"assertion":[{"value":"23 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}